Antonio Passaro

Background

About Antonio Passaro

Antonio Passaro (MD-PhD) is a Senior Staff Physician, with a PhD in molecular medicine, at the European Institute of Oncology (IEO), Milan, Italy. He is a specialist in lung cancer with a focus on predictive biomarkers, target agents, and immunotherapy. Dr. Passaro is a member of the ESMO Council where he serves as the Chair of the Communications Committee. He is an author of more than 130 peer-reviewed publications and is actively involved in clinical trials and translational research. Dr. Passaro's foremost research endeavors are dedicated to pioneering targeted therapies tailored specifically for non-small cell lung cancer (NSCLC) with driver alterations. Simultaneously, he advocates for the personalized application of immunotherapy, guided by clinical and biological biomarkers. This dual approach reflects his commitment to advancing precision medicine in the treatment of NSCLC. Beyond his academic pursuits, Dr. Passaro is an advocate for utilizing social media in healthcare and oncology. He has conducted extensive national and international reports and workshops, showcasing his dedication to advancing these fields through innovative communication channels